MINI FUTURE LONG - MERCK & CO. | Market Closed - Börse Stuttgart 20:41:30 25/06/2024 BST | ||
| 4.88 EUR | +0.21% |
|
| Current month | +18.73% | ||
| 1 month | +7.73% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 25/06/24 | 4.88 | +0.21% |
| 24/06/24 | 4.87 | +5.18% |
| 21/06/24 | 4.63 | +0.87% |
| 20/06/24 | 4.59 | +5.03% |
| 19/06/24 | 4.37 | -0.91% |
Delayed Quote Börse Stuttgart
Last update June 25, 2024 at 08:41 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MD6XH5 |
| ISIN | DE000MD6XH51 |
| Date issued | 08/08/2022 |
| Strike | 80.59 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.54 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.93 € |
|---|---|
| Lowest since issue | 1.3 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
132.9
USD
Average target price
142.7
USD
Spread / Average Target
+7.34%
- Stock Market
- Certificates
- Certificat
